EndoCross
Medical Devices for Cardiovascular Treatment
Company Overview
Snapshot
Founded in January 2006 by Eran Hirszowicz, EndoCross operates with over 12,000 employees. The company has raised $2.5M across one funding round from two investors. In September 2014, its ENABLER-C System for crossing total coronary occlusions received European approval.
Business overview
EndoCross develops and markets medical devices for cardiovascular treatment, focusing on solutions for challenging lesions, including chronic total occlusions (CTOs). Its core technology, the ENABLER Catheter System, is designed to advance guidewires in complex environments, utilizing traditional balloon technologies for guidewire support, centralization, and controlled advancement. The company's product portfolio includes the ENABLER-P Catheter System for peripheral vasculature and the ENABLER-C Catheter System for coronary environments. EndoCross serves the healthcare industry, specifically hospitals and providers, operating within the Health Tech & Life Sciences sector, with a focus on Medical Devices and Medical Treatment & Therapeutics.
Strategic signal
In September 2014, EndoCross received European approval for its ENABLER-C System, designed for crossing total coronary occlusions. This regulatory milestone is significant as it validates the company's technology for a critical application in cardiovascular health, opening up market access in Europe for a specialized medical device. For investors, this signals a key step in product commercialization and market penetration within the competitive medical device landscape.
Log in to access full profile ›Company Intelligence Q&A
- When was EndoCross founded?
- EndoCross was founded in January 2006 by Eran Hirszowicz.
- What is the primary focus of EndoCross's products?
- EndoCross primarily focuses on developing and marketing solutions to treat challenging cardiovascular lesions, including chronic total occlusions (CTOs).
- Which of EndoCross's products received European approval?
- In September 2014, EndoCross's ENABLER-C System for crossing total coronary occlusions received European approval.
- What is the ENABLER-P Catheter System designed for?
- The ENABLER-P Catheter System is designed for use in the peripheral vasculature, including above-the-knee and below-the-knee vessels.
- What was the total amount of funding raised by EndoCross?
- EndoCross raised a total of $2.5M across one funding round in November 2008, with investments from Viola Growth and Ofer Hi-Tech.